Michaela Fontenay

17PUBLICATIONS
118CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMedical mycologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 04, 2026
High frequency of CD95+/CD45RA- regulatory T cells defines an immunosuppressive profile associated with MDS progression.

|Jan 24, 2025
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

David Rombaut, Sarah Sandmann, Tobias Tekath

|Jul 03, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Elsa Bernard, Robert P Hasserjian, Peter L Greenberg

|Apr 08, 2024
Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.

David Rombaut, Carine Lefèvre, Tony Rached

|Oct 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini

|Apr 30, 2021
ImmunoCluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data.

James W Opzoomer, Jessica A Timms, Kevin Blighe

Pageof 3

Frequent Collaborators

4 joint publications

Michael R Savona

4 joint publications

Jacqueline Boultwood

4 joint publications

Guillermo Sanz

4 joint publications

Christina Ganster